Associations between cardiovascular risk factors and psoriasis in Iran

Figures & data

Table 1 Univariate analysis for cardiovascular risk factors in psoriasis patients compared with the control group

Variable	Psoriasis patients (mean ± SD)	Controls (mean ± SD)	P-value
Age	47.30±18.40	45.16±15.90	0.5
TG	152.60±72.00	107.05±35.00	P<0.001
HDL	66.00±10.40	49.00±9.00	0.1
LDL	106.00±36.00	89.80±31.30	0.01
BMI	26.36±4.71	24.60±3.00	0.02
Diastolic BP	81.11±11.30	74.04±10.90	0.003
Systolic BP	135.83±19.00	118.10±16.00	P<0.001
Cholesterol total	184.00±47.10	165.00±38.00	0.02
FBS	101.00±25.70	96.00±14.40	0.1

Abbreviations: TG, triglyceride; HDL, high-density lipoprotein cholesterol; LDL, low-density lipoprotein cholesterol; BMI, body mass index; BP, blood pressure; FBS, fasting blood glucose.

Table 2 Final multivariable logistic regression model for assessment of determined variables

Variable	Odds ratio	P-value	95% confidence interval
Smoking	2.20	0.02	1.1–3.2
Triglyceride	1.02	0.005	1–1.34
Total cholesterol	0.96	0.60	0.001–0.93
LDL (mg/dL)	1.04	0.03	1–1.09
BMI (kg/m^2)	1.10	0.07	0.33–2.1
Systolic BP	1.07	0.004	1.02–1.33
Diastolic BP	0.96	0.32	0.89–1.03

Abbreviations: LDL, low-density lipoprotein cholesterol; BMI, body mass index; BP, blood pressure.